Sept 30 (Reuters) – Liquidia shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes key patent held by rival United Therapeutics , dealing a major blow to the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Corrects lede to say inflation rate held steady at 3.1%, not inflation rate rose by…
VIDEO SHOWS: FILE OF NIKE, UEFA, CHAMPIONS LEAGUE AND MAJOR EUROPEAN CLUBS TRAINING RESENDING WITH…
PARIS, Nov 17 (Reuters) - France's farm ministry on Tuesday cut its forecast for 2026…
Kolkata (West Bengal) [India], November 17: NIS Management Limited (BSE – 544495), one of the…
By Emma Rumney LONDON, Nov 17 (Reuters) - US authorities uncovered a factory producing illegal vapes…
By Karen Freifeld WASHINGTON, Nov 16 (Reuters) - The Trump administration said on Monday it…